Atlina Lifesciences Expands Its Footprint in Ethical Pharmaceutical Marketing Across India and Beyond

Atlina Lifesciences Private Limited, a leading ISO 9001:2015 and WHO-GMP certified pharmaceutical marketing company, proudly announces its continued growth and expansion across India and international territories, reinforcing its mission to deliver high-quality, ethical, and innovative healthcare solutions.

Established in 2016 and backed by over 25 years of pharmaceutical legacy, Atlina Lifesciences has built a strong reputation for offering over 700+ quality-assured formulations across all major therapeutic segments. The company operates through a robust ethical PCD franchise model, along with third-party manufacturing and white-label partnerships.

With a strong presence in pan-India locations and branch offices in Gurgaon and Australia, Atlina Lifesciences offers an extensive product range that includes general medicines, nutraceuticals, pediatric care, dermatology, cardiac-diabetic, and specialty formulations. All products are manufactured under strict WHO-GMP, CGMP, and ISO standards, supported by innovative branding, fast logistics, and dedicated account support.

Atlina Lifesciences also caters to international markets with an expanding export division, offering a full suite of documentation (COPP, COA, MSDS, Dossiers) and customized packaging solutions.